|
Jan 9
|
Grifols Denies Gotham Claims as Short Seller Triggers 26% Rout
|
|
Jan 9
|
Factbox-What is Grifols and why have its shares slumped?
|
|
Jan 9
|
Grifols Stock Tanks, Short Seller Alleges Profit Manipulation, Concerning Financial Health
|
|
Jan 9
|
Grifols Sinks as Short Seller Gotham Criticizes Accounting
|
|
Jan 9
|
Spain's Grifols slumps after short-seller accuses healthcare group of fraud
|
|
Jan 9
|
Gotham City accounting queries wipe $3 billion off Grifols value
|
|
Jan 4
|
3 Cheap Stocks to Buy for Growth & Value
|
|
Dec 14
|
Are You Looking for a Top Momentum Pick? Why Grifols (GRFS) is a Great Choice
|
|
Dec 11
|
5 Best Breakout Stocks to Invest in for Attractive Returns
|
|
Dec 7
|
GRFS vs. ZTS: Which Stock Is the Better Value Option?
|
|
Sep 28
|
GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564
|
|
Jul 21
|
Should Value Investors Buy Grifols (GRFS) Stock?
|
|
Jul 20
|
Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients
|
|
Jul 18
|
Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis
|